{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:06:20Z","timestamp":1786356380048,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI098775"],"award-info":[{"award-number":["R01AI098775"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.xphs.2017.04.037","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T16:00:46Z","timestamp":1493222446000},"page":"1961-1970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate"],"prefix":"10.1016","volume":"106","author":[{"given":"Wen-Hsiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivali M.","family":"Chag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan V.","family":"Poongavanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadeo B.","family":"Biter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebe A.","family":"Ewere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderson","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Seid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Hudspeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Pollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Patrick","family":"McAtee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Strych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Hotez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2017.04.037_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Reviews Microbiol"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.037_bib2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections: implications for SARS","volume":"5","author":"Perlman","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"10.1016\/j.xphs.2017.04.037_bib3","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A\u00a0double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.xphs.2017.04.037_bib4","first-page":"31","article-title":"SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement","volume":"18 Suppl 2","author":"Jaume","year":"2012","journal-title":"Hong Kong Med J"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.037_bib5","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A\u00a0193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"10.1016\/j.xphs.2017.04.037_bib6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1586\/erv.12.126","article-title":"Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome","volume":"11","author":"Jiang","year":"2012","journal-title":"Expert Rev Vaccin"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.037_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2009.05.003","article-title":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells","volume":"384","author":"Du","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.037_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","article-title":"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity","volume":"393","author":"Du","year":"2009","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.xphs.2017.04.037_bib9","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.037_bib10","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.4049\/jimmunol.176.10.6085","article-title":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein","volume":"176","author":"He","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"15","key":"10.1016\/j.xphs.2017.04.037_bib11","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.vaccine.2006.10.031","article-title":"Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model","volume":"25","author":"Du","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.037_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/vim.2009.0090","article-title":"A\u00a0219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity","volume":"23","author":"Du","year":"2010","journal-title":"Viral Immunol"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.037_bib13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/hv.27464","article-title":"Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate","volume":"10","author":"Chen","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.037_bib14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1086\/381901","article-title":"Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum","volume":"189","author":"Goud","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.037_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/bp0603199","article-title":"Enhancing the production of Fc fusion protein in fed-batch fermentation of Pichia pastoris by design of experiments","volume":"23","author":"Lin","year":"2007","journal-title":"Biotechnol Prog"},{"issue":"1-2","key":"10.1016\/j.xphs.2017.04.037_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jim.2005.07.021","article-title":"A\u00a0quantitative slot blot assay for host cell protein impurities in recombinant proteins expressed in E. coli","volume":"306","author":"Zhu","year":"2005","journal-title":"J\u00a0Immunol Methods"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.037_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4161\/hv.19726","article-title":"Advances in vaccines against neglected tropical diseases","volume":"8","author":"Plieskatt","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.037_bib18","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.4161\/hv.28872","article-title":"Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate","volume":"10","author":"Curti","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.037_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0003-2697(87)90157-6","article-title":"Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces","volume":"167","author":"Sackett","year":"1987","journal-title":"Anal Biochem"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.037_bib20","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1021\/jf970876y","article-title":"Hydrophobicity of bovine serum albumin and ovalbumin determined using uncharged (PRODAN) and anionic (ANS-) fluorescent probes","volume":"46","author":"Haskard","year":"1998","journal-title":"J\u00a0Agric Food Chem"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.037_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0005-2795(80)90220-2","article-title":"Hydrophobicity determined by a fluorescence probe method and its correlation with surface properties of proteins","volume":"624","author":"Kato","year":"1980","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.xphs.2017.04.037_bib22","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.bpj.2010.08.020","article-title":"Diffusion and sedimentation interaction parameters for measuring the second virial coefficient and their utility as predictors of protein aggregation","volume":"99","author":"Saluja","year":"2010","journal-title":"Biophys J"},{"issue":"18","key":"10.1016\/j.xphs.2017.04.037_bib23","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1016\/S0021-9258(17)39198-6","article-title":"Why does Coomassie Brilliant Blue R interact differently with different proteins? A partial answer","volume":"260","author":"Tal","year":"1985","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.037_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-7-299","article-title":"Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients","volume":"7","author":"Cao","year":"2010","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.037_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01575883","article-title":"High-level secretion of biologically active aprotinin from the yeast Pichia pastoris","volume":"7","author":"Vedvick","year":"1991","journal-title":"J\u00a0Ind Microbiol"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.037_bib26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/(SICI)1097-0061(199908)15:11<1087::AID-YEA436>3.0.CO;2-F","article-title":"High-yield secretion of recombinant gelatins by Pichia pastoris","volume":"15","author":"Werten","year":"1999","journal-title":"Yeast"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.037_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0167-7799(02)01933-9","article-title":"Filamentous fungi as cell factories for heterologous protein production","volume":"20","author":"Punt","year":"2002","journal-title":"Trends Biotechnol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.037_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0958-1669(02)00330-0","article-title":"Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris","volume":"13","author":"Cereghino","year":"2002","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.037_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10295-012-1220-z","article-title":"A\u00a0simple Pichia pastoris fermentation and downstream processing strategy for making recombinant pandemic Swine Origin Influenza A virus Hemagglutinin protein","volume":"40","author":"Athmaram","year":"2013","journal-title":"J\u00a0Ind Microbiol Biotechnol"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.037_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pep.2012.03.013","article-title":"Expression, purification, and molecular analysis of the Necator americanus glutathione S-transferase 1 (Na-GST-1): a production process developed for a lead candidate recombinant hookworm vaccine antigen","volume":"83","author":"Goud","year":"2012","journal-title":"Protein Expr Purif"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.037_bib31","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.4161\/hv.25787","article-title":"Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: a vaccine candidate for human intestinal schistosomiasis","volume":"9","author":"Curti","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.037_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0003-2697(79)90732-2","article-title":"A\u00a0highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels","volume":"98","author":"Switzer","year":"1979","journal-title":"Anal Biochem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917302733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917302733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T11:23:43Z","timestamp":1655551423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917302733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0022354917302733"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.037","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}]}}